NCT02914132View on ClinicalTrials.gov

Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 7, 2018

Study Completion Date

June 7, 2018

Conditions
BacteremiaBacterial Infection
Interventions
DEVICE

Seraph 100 Filter

Treatment of renal replacement therapy patients with bacteremia.

Trial Locations (4)

30625

Medizinische Hochschule-Hannover, Hannover

38126

Klinikum Braunschweig, Braunschweig

48149

Universitatsklinikum Muenster, Münster

Unknown

Universitaetsklinikum-Frankfurt, Frankfurt

Sponsors
All Listed Sponsors
lead

ExThera Medical Corporation

INDUSTRY

NCT02914132 - Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis | Biotech Hunter | Biotech Hunter